Hikma Pharmaceuticals PLC Annual report 2010 notes to tHe ComPAny FInAnCIAL stAtements Continued 46.
FInAnCIAL Assets Cash and cash equivalents These comprise cash held by the Company and short-term bank deposits with an original maturity of three months or less.
The carrying amount ofthese assets approximates to their fair value.
FInAnCIAL LIABILItIes other payables The Directors consider that the carrying amount of other payables approximates to their fair value.
48. due to suBsIdIArIes Due to subsidiaries mainly represents an amount due to Hikma Holdings UK Ltd which is a non interest bearing loan repayable on demand.
FInAnCIAL PoLICIes For rIsk mAnAGement And tHeIr oBJeCtIves Currency risk Currency risks as defined by IFRS 7 arise on account of financial instruments being denominated in a currency that is not the functional currency and being of a monetary nature.
The following table illustrates financial assets and liabilities for the Company in different currencies: Liabilities Assets 2010 2009 2010 2009 $000 $000 $000 $000 euro 87 125 30 GBP 1,191 788 580 183 A sensitivity analysis based on a 1% movement in foreign exchange rates has no material impact on the Company results and Company statement of changes in equity.
Further details on how the Company manages the currency risk are given in Note 29 to the Group accounts.
Interest rate risk An interest rate sensitivity analysis assumes an instantaneous 100 basis point change in interest rates in all currencies from their levels at 31December 2010, with all other variable held constant.
Based on the composition of the Company debt portfolio as at 31 December 2010, a1%increase in interest rates would result in no additional interest expense being incurred per year 2009: USD nil.
Liquidity risk: Less than one year 2010 $000 Cash and cash equivalents 3,063 Accounts receivables 93 other payables 255 2,901 124
